Rare diseases
Investigational molecules
Locations
Kyjevska 44, 532 03 Pardubice, Czechia
Multiscan s.r.o. in Pardubice, Czechia specialises in clinical trials of conditions such as Hormone-refractory prostate cancer, Prostate cancer metastatic, Squamous cell carcinoma of lung, Non-small cell lung cancer, and other specialisations. This site conducts important research.
Clinical trials currently enrolling participants at this site.
Study of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
CzechiaA study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer
CzechiaStudy comparing NVL-655 to alectinib in untreated patients with ALK-positive advanced non-small cell lung cancer
CzechiaStudy of PF-06821497 and Enzalutamide for Men with Advanced Prostate Cancer Resistant to Hormone Therapy
CzechiaStudy of Pembrolizumab and MK-2870 for Patients with Metastatic Squamous Non-small Cell Lung Cancer
CzechiaStudy Comparing MK-2870 and Pembrolizumab Combination to Pembrolizumab Alone for Patients with Metastatic Non-Small Cell Lung Cancer with High PD-L1 Levels
CzechiaStudy of PF-06821497 with Enzalutamide for Men with Metastatic Castration-Resistant Prostate Cancer Previously Treated with Abiraterone Acetate
CzechiaStudy on Capivasertib and Docetaxel for Treating Metastatic Castration-Resistant Prostate Cancer in Patients
CzechiaStudy Comparing Abemaciclib and Fulvestrant with Placebo and Fulvestrant for Patients with Advanced or Metastatic Breast Cancer After Previous Treatment
CzechiaStudy on the Effectiveness and Safety of Apalutamide and GnRH Agonist in Patients with High-Risk Prostate Cancer Undergoing Radiation Therapy
CzechiaStudy on Talazoparib and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
CzechiaGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
